OPHLY Stock Price, Chart, Stats & News
Ono Pharmaceutical Co., Ltd. (OPHLY) is a dividend-paying stock with a current dividend yield of 8.07% as of Sep 25, 2026. It pays $0.4188 per share over the trailing twelve months. Its dividend has grown at a 9.35% 5-year compound annual rate.
Dividend safety
OPHLY pays out about 119% of earnings, leaving little safety margin.
OPHLY chart
About
Ono Pharmaceutical Co., Ltd., along with its subsidiaries, operates globally, engaging in the research, development, procurement, and commercialization of pharmaceutical products and diagnostic reagents. Its current portfolio features a range of established treatments, notably in oncology, with products such as the intravenous infusions OPDIVO and KYPROLIS, alongside MEKTOVI, VELEXBRU, ADLUMIZ (tablets), and BRAFTOVI (capsules) for various malignant tumors. Other specialized oncology support includes EMEND capsules and PROEMEND intravenous injections to manage chemotherapy-induced nausea and vomiting, and DEMSER capsules for symptomatic improvement in pheochromocytoma patients.
Related lists
Similar securities
Based on sector and market capitalization
